Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban PK/PD and Safety in Hemodiafiltration
NCT04952792Phase 2Completed
- Sponsor
- Bellvitge University Hospital
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apixaban in Atrial fibrillation (AFib), sponsored by Bellvitge University Hospital. Started May 2021; status: completed.
02
Drugs
apixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT04952792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04952792.